EP Patent
EP0274259B1 — New renin-inhibitory oligopeptides, their preparaton and their use
Assigned to Sankyo Co Ltd · Expires 1994-02-16 · 32y expired
What this patent protects
Patent listed against Zulresso.
Drugs covered by this patent
- Zulresso (BREXANOLONE) · Sage Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.